[Correction of oxidative stress in patients with chronic cerebral ischemia]

O A Goroshko,K N Novikov,V G Kukes,V L Voeikov,E V Buravleva,A S Zhestovskaya,N G Berdnikova,V V Arkhipov
Abstract:A pilot study of the effect of the antioxidant drug ethylmethylhydroxypyridine malate on indicators of oxidative stress in patients with chronic cerebral ischemia. At 6 day course administration investigated the antioxidant in these patients significantly accelerates the process of generation of superoxide anion radical, established by lucigenin-depended chemiluminescence that probably regulate a feedback mechanism oxidase systems. This increases the activity of superoxide dismutase, and reduced the concentration of secondary peroxidation product - malondialdehyde, making reasonable use of antioxidants in the treatment of this pathology.
What problem does this paper attempt to address?